Load sharing between synergistic muscles characterized by a ligand-binding approach and elastography

The skeletal muscle contraction is determined by cross-bridge formation between the myosin heads and the actin active sites. When the muscle contracts, it shortens, increasing its longitudinal shear elastic modulus ([Formula: see text]). Structurally, skeletal muscle can be considered analogous to the molecular receptors that form receptor-ligand complexes and exhibit specific ligand-binding dynamics. In this context, this work aims to apply elastography and the ligand-binding framework to approach the possible intrinsic mechanisms behind muscle synergism. Based on the short-range stiffness principle and the acoustic-elasticity theory, we define the coefficient [Formula: see text], which is directly related to the fraction saturation of molecular receptors and links the relative longitudinal deformation of the muscle to its [Formula: see text]. We show that such a coefficient can be obtained directly from [Formula: see text] estimates, thus calculating it for the biceps brachii, brachioradialis, and brachialis muscles during isometric elbow flexion torque (τ) ramps. The resulting [Formula: see text] curves were analyzed by conventional characterization methods of receptor-ligand systems to study the dynamical behavior of each muscle. The results showed that, depending on muscle, [Formula: see text] exhibits typical ligand-binding dynamics during joint torque production. Therefore, the above indicates that these different behaviors describe the longitudinal shortening pattern of each muscle during load sharing. As a plausible interpretation, we suggested that this could be related to the binding kinetics of the cross-bridges during their synergistic action as torque increases. Likewise, it shows that elastography could be useful to assess contractile processes at different scales related to the change in the mechanical properties of skeletal muscle.

Surface wave elastography is a reliable method to correlate muscle elasticity, torque, and electromyography activity level

The shear elastic modulus is one of the most important parameters to characterize the mechanical behavior of soft tissues. In biomechanics, ultrasound elastography is the gold standard for measuring and mapping it locally in skeletal muscle in vivo. However, their applications are limited to the laboratory or clinic. Thus, low-frequency elastography methods have recently emerged as a novel alternative to ultrasound elastography. Avoiding the use of high frequencies, these methods allow obtaining a mean value of bulk shear elasticity. However, they are frequently susceptible to diffraction, guided waves, and near field effects, which introduces biases in the estimates. The goal of this work is to test the performance of the non-ultrasound surface wave elastography (NU-SWE), which is portable and is based on new algorithms designed to correct the incidence of such effects. Thus, we show its first application to muscle biomechanics. We performed two experiments to assess the relationships of muscle shear elasticity versus joint torque (experiment 1) and the electromyographic activity level (experiment 2). Our results were comparable regarding previous works using the reference ultrasonic methods. Thus, the NU-SWE showed its potentiality to get wide the biomechanical applications of elastography in many areas of health and sports sciences.

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal. We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP. Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes. From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7. The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel. These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.